STC2 and colorectal carcinoma: The underlying mechanisms were further explored by RNA sequencing, RNA immunoprecipitation (RIP), and RNA stability assays.<h4>Results</h4>STC2 was significantly upregulated in CRC tissues and cell lines, and its high expression was associated with poor prognosis in CRC patients.